BASEL, Switzerland--(BUSINESS WIRE)--Syngenta announced today that the registration of its SDHI fungicide SOLATENOL™ has been further extended in Europe following approval by the German authorities. This most recent registration will allow Syngenta to introduce the products ELATUS™ Era and ELATUS™ Plus to the cereals market in Germany. ELATUS™ Plus is a solo formulation of the active ingredient SOLATENOLTM sold in co-packs with a range of other products. ELATUS™ Era is a combination of the two active ingredients SOLATENOLTM and prothioconazole.
The launch of SOLATENOL™ in Germany for the 2017 season gives growers in another major cereals market access to this leading new technology. SOLATENOL™ is already registered in France, Croatia, UK, Ireland, Finland, Latvia, Estonia and Austria.
SOLATENOL™ is a carboxamide fungicide offering an unrivaled performance against Septoria and rusts - two important diseases which can significantly impact cereals production. In trials, it has proven to be extremely consistent in providing excellent disease control on all important cereals varieties in a wide range of situations over several years. The product offers outstanding levels of leaf protection resulting in higher yield and return on investment for the farmer.
SOLATENOL™ is also available for use on soybean in Latin America and on a wide range of crops in the USA and Canada.
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.